Effects of various nitrates on pulmonary wedge pressure in acute myocardial infarction. 1990

S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
Department of Internal Diseases, M. Gorky Medical Institute, Donetsk, USSR.

122 patients with acute myocardial infarction showing a positive antianginal response to nitroglycerin were examined. With the patients under continuous haemodynamic control including pulmonary artery catheterization the circulatory response to various nitrates administered orally, sublingually or transdermally was investigated. A safe time interval was determined for each drug to ensure stability of the attained wedge pressure reduction.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D011669 Pulmonary Wedge Pressure The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES. Pulmonary Artery Wedge Pressure,Pulmonary Capillary Wedge Pressure,Pulmonary Venous Wedge Pressure,Wedge Pressure,Pressure, Pulmonary Wedge,Pressures, Pulmonary Wedge,Pulmonary Wedge Pressures,Wedge Pressure, Pulmonary,Wedge Pressures, Pulmonary,Pressure, Wedge,Pressures, Wedge,Wedge Pressures
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000286 Administration, Sublingual Administration of a soluble dosage form by placement under the tongue. Drug Administration, Sublingual,Sublingual Drug Administration,Sublingual Administration,Administration, Sublingual Drug,Administrations, Sublingual,Administrations, Sublingual Drug,Drug Administrations, Sublingual,Sublingual Administrations,Sublingual Drug Administrations
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
January 1994, Klinicheskaia meditsina,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
February 1991, Japanese circulation journal,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
February 1975, Kokyu to junkan. Respiration & circulation,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
January 1984, Scandinavian journal of clinical and laboratory investigation. Supplementum,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
January 1987, Drugs,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
January 1975, Kokyu to junkan. Respiration & circulation,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
February 1987, Chest,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
July 1990, European heart journal,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
July 1971, The New England journal of medicine,
S I Roshchin, and V M Berezov, and A M Varlamov, and V K Boch, and G N Roshchina, and S N Verzilov
May 1996, The American journal of cardiology,
Copied contents to your clipboard!